Age, Biography and Wiki

Charles Brenton Huggins was born on 22 September, 1901 in Halifax, Nova Scotia, Canada, is an American physician. Discover Charles Brenton Huggins's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 96 years old?

Popular As N/A
Occupation N/A
Age 96 years old
Zodiac Sign Virgo
Born 22 September, 1901
Birthday 22 September
Birthplace Halifax, Nova Scotia, Canada
Date of death 1997
Died Place Chicago, Illinois, U.S.
Nationality Canada

We recommend you to check the complete list of Famous People born on 22 September. He is a member of famous physician with the age 96 years old group.

Charles Brenton Huggins Height, Weight & Measurements

At 96 years old, Charles Brenton Huggins height not available right now. We will update Charles Brenton Huggins's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Charles Brenton Huggins Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Charles Brenton Huggins worth at the age of 96 years old? Charles Brenton Huggins’s income source is mostly from being a successful physician. He is from Canada. We have estimated Charles Brenton Huggins's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income physician

Charles Brenton Huggins Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1901

Charles Brenton Huggins (September 22, 1901 – January 12, 1997) was a Canadian-American surgeon and physiologist known for his work on prostate function, prostate cancer, and breast cancer.

Born in Halifax in 1901, Huggins moved to the United States for medical school.

He was one of the founding staff members of the University of Chicago Medical School, where he remained for the duration of his professional research career.

Huggins' work on how sex hormones influence prostate function ultimately led to his discovery of hormone therapies to treat prostate cancer.

Charles Brenton Huggins was born September 22nd, 1901 in Halifax, Nova Scotia to Charles E. Huggins and Bessie Maria Spencer.

At 19, he graduated from Acadia University with a BA degree, supplementing his Acadia coursework with summer courses in physical and organic chemistry at Columbia University.

1924

Huggins went on to Harvard Medical School, and received his MD degree in 1924.

He served his internship and residency in general surgery with Frederick A. Coller at the University of Michigan.

1927

While at Michigan, Huggins met operating room nurse Margaret Wellman; they married in 1927.

In 1927, Huggins was recruited to the new University of Chicago Medical School by chairman of surgery Dallas Phemister.

As one of the eight original staff members of the school, Huggins was assigned the urology department, and had to rapidly teach himself the specialty.

1930

Through the 1930s, Huggins published work characterizing the constituents of semen and which organ (seminal vesicles or prostate) they derive from.

1931

In 1931, Phemister offered Huggins a paid research sabbatical in Europe; Huggins spent several months at London's Lister Institute working in Robert Robison's lab to deepen his knowledge in biochemistry.

1933

He was promoted to associate professor in 1933, and full professor in 1936.

1939

In 1939, Huggins described a method for isolating prostate fluid from dogs, which served as the foundation for much of his subsequent work.

He showed that the prostate requires androgens (male sex hormones) in order to function, and that androgen treatment could be counteracted by treatment with estrogens.

In the course of this work, he discovered that older dogs tended to have enlarged prostates, and that these enlarged prostates could be shrunk by administering estrogen.

1940

In 1940 and 1941, Huggins – along with students Clarence V. Hodges and William Wallace Scott – published a series of three papers detailing his most famous finding: that counteracting androgen activity by orchiectomy (surgical removal of the testicles) or estrogen treatment shrunk tumors in many men with metastatic prostate cancer.

These men experienced dramatic pain relief within days of the treatment; four of the original 21 treated went on to survive more than 12 years from the original treatment.

Huggins' work on prostate cancer often necessitated measuring the amount of prostate-derived enzymes in the blood.

To this end, Huggins developed colorimetric methods for quantifying the concentration of various phosphatases, glucuronidases, and esterases.

These assays relied on "chromogenic substrates" (substances that change color in response to a given enzyme), a term Huggins coined, and a concept he pioneered.

1949

Huggins was elected to the United States National Academy of Sciences and the American Academy of Arts and Sciences in 1949.

1950

In the 1950s, Huggins went on to show an analogous relationship between sex hormones and breast cancer – tumor growth was stimulated by estrogens, and slowed by androgens.

At the time breast cancer research was hindered by the lack of an animal model.

Huggins described the first reliable model: 7,12-dimethylbenz(a)anthracene administered orally to rats, 100% of which rapidly developed breast tumors; the model is now called "Huggins Tumor".

Around this time, Huggins wound down his surgical practice, turning his attention to full-time scientific research.

Altogether, Huggins published over 200 peer-reviewed papers describing his research.

1951

In 1951, businessman and longtime financial supporter of Huggins' research Ben E. May endowed the Ben May Laboratory for Cancer Research at the University of Chicago.

1962

In 1962, he was granted an endowed professorship, the William B. Ogden Distinguished Service Professor.

Huggins' early research work focused on bone physiology.

However, he eventually felt this bone work was unlikely to lead to medical progress, and set it aside in favor of studying the male urogenital tract.

In 1962, he was elected to the American Philosophical Society, and was awarded the Lasker Award the following year.

1966

For this finding, he was awarded the 1966 Nobel Prize for Physiology or Medicine.

In addition to his work on prostate cancer, Huggins explored the relationship between hormones and breast cancer, developed an animal model for breast cancer, and developed "chromogenic substrate"s that are widely used for biochemical analyses.

In 1966, following nominations from noted surgeon J. Hartwell Harrison as well as Nobel laureates Otto H. Warburg, William P. Murphy, and Albert Szent-Györgyi, Huggins was awarded the Nobel Prize in Physiology or Medicine "for his discoveries concerning hormonal treatment of prostatic cancer".

1969

Huggins eventually became the May Laboratory's director, serving in the position until 1969.

1972

From 1972–1979, Huggins was named the ceremonial chancellor of his alma mater, Acadia University.

His prize, shared with fellow cancer researcher Peyton Rous, was just the second Nobel for cancer treatment or research.

1997

Huggins continued to perform research into his 90s; he died in Chicago in 1997.